Delivery Order SPE2DB20D3101-SPE2DB21FK6C0

Award Date 9/22/21
Potential Completion Date 9/23/21
Potential Value $35K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,866.04 and a completion date of November 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,792.74 firm-fixed-price delivery order is for the supply of Vemlidy 25 mg tablets to support military healthcare needs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Vemlidy 25 mg tablets. The contract, valued at $10,975.25, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The contract, valued at $2,527.80, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp's Corporate Office division. The $21,147.99 firm-fixed-price delivery order is for the supply of 4,565,091 units of the prescription medication Vemlidy 25 mg tablets. The contract has a period of performance through July 9, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.74 firm fixed-price delivery order is for the provision of Vemlidy 25 mg tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $77,861.38 delivery order contract is for Vemlidy 25mg tablets, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of Vemlidy 25 mg tablets. The contract is a Delivery Order with a Firm Fixed Price type, valued at $2,858.01, and has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,176.68 firm-fixed-price delivery order is for the supply of Vemlidy 25 mg tablets. The contract has a period of performance through November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,731.02 firm fixed-price delivery order is for Vemlidy 25 mg tablets. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK6C0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The $34,970.40 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract does not have a set-aside designation, indicating open competition. The parent company of the awardee is Cencora, Inc., which also does business as AmerisourceBergen.

Generated 2/27/25, 10:08 AM